Lincoln Capital Corp Merck & Co., Inc. Transaction History

Lincoln Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 26, 2018	SELL	$50.83 - $59.72 $255,014 - $299,615	-5,017 Closed	0 $0
Q1 2018 Apr 12, 2018	SELL	$50.96 - $59.23 $1.53 Million - $1.78 Million	-30,075 Reduced 85.7%	5,017 $273,000
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $1.54 Million - $1.83 Million	-29,748 Reduced 45.88%	35,092 $1.98 Million
Q3 2017 Oct 18, 2017	BUY	$58.67 - $63.13 $3.8 Million - $4.09 Million	64,840	64,840 $4.15 Million

3,825

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln Capital Corp with notifications on news.